Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.
Campistol
J M
JM
Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
Mazuecos
A
A
Segura
J
J
Osuna
A
A
Herrero
J C
JC
Andres
A
A
Oppenheimer
F
F
Gomez de la Camara
A
A
Martinez
M A
MA
Morales
J M
JM
D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D001794:Blood Pressure; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010865:Pilot Projects; D011241:Prednisone / Q000627:therapeutic use; D012044:Regression Analysis; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone